再酯化甘油三酯型 omega-3 补充剂对白内障术后干眼的影响
这项前瞻性比较队列研究纳入 66 例白内障术后 1 个月出现新发非特异性典型干眼的患者,随机分为对照组和 omega-3 组(在人工泪液基础上全身补充再酯化甘油三酯型 omega-3 脂肪酸 2 个月)。结果显示 omega-3 组 Oxford 评分低于对照组,OSDI 和 DEQ 主观症状评分改善(均 p<0.05),MMP-9 升高比例低于对照组(p=0.027)。结论提示该补充剂可能通过减轻眼表炎症而非促进泪液分泌发挥作用。
要点
- 白内障术后干眼患者补充 rTG 型 omega-3 两个月可改善 OSDI 和 DEQ 主观症状评分。
- omega-3 组 Oxford 评分低于对照组,MMP-9 升高比例更低(p=0.027)。
- 获益可能与减轻眼表炎症相关,而非增加泪液分泌。
核心结论
- 再酯化甘油三酯型 omega-3 补充剂可能通过减轻眼表炎症而非促进泪液分泌,对无并发症白内障术后非特异性典型干眼有效。
研究设计与样本
- 前瞻性比较队列研究,纳入 66 例无并发症白内障术后 1 个月出现新发非特异性典型干眼的患者。
- 受试者随机分为对照组和 omega-3 组,omega-3 组在人工泪液基础上全身补充 rTG 型 omega-3 脂肪酸 2 个月。
- 在补充前后评估眼表参数(Schirmer 试验、泪膜破裂时间、角膜染色评分、MMP-9)及主观问卷(OSDI、DEQ)。
主要发现
- 补充 omega-3 两个月后,omega-3 组 Oxford 评分低于对照组。
- omega-3 组 OSDI 和 DEQ 主观症状评分均改善(均 p<0.05)。
- omega-3 组 MMP-9 水平升高比例低于对照组(p=0.027)。
临床怎么用
- 对无并发症白内障术后出现非特异性典型干眼的患者,可考虑在人工泪液基础上短期补充 rTG 型 omega-3 以改善主观症状和眼表炎症指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To evaluate the clinical outcomes of the systemic re-esterified triglyceride (rTG) form of omega-3 fatty acids in patients with dry eye symptoms after cataract surgery. METHODS: This prospective comparative cohort study comprised 66 patients complaining of new-onset non-specific typical dry eye 1 month after uncomplicated cataract surgery. Subjects were randomly allocated into control and omega-3 groups based on administration of the systemic rTG form of omega-3 fatty acids for 2 months, in addition to use of artificial teardrop. Ocular surface parameters (Schirmer's test, tear break-up time, corneal staining score and matrix metalloproteinase-9 (MMP-9)) and subjective questionnaire results (Ocular Surface Disease Index (OSDI)) and Dry Eye Questionnaire [DEQ]) for dry eye were evaluated before and after omega-3 supplementation. RESULTS: Two months after omega-3 supplementation, the Oxford score was lower in the omega-3 group than in the control group. There was an improvement of subjective symptom scores of OSDI and DEQ in the omega-3 group (both p<0.05). The ratio of increasing MMP-9 level in the omega-3 group was lower than that in the control group (p=0.027). CONCLUSION: The rTG form of omega-3 supplementation might be related to reduction of ocular surface inflammation rather than secretion of tears, and it might be effective for non-specific typical dry eye after uncomplicated cataract surgery. TRIAL REGISTRATION NUMBER: NCT04411615.
引用
- Park J, Yoo YS, Shin E, et al. Effects of the re-esterified triglyceride (rTG) form of omega-3 supplements on dry eye following cataract surgery. Br J Ophthalmol. 2020. PMID: 32917627. doi:10.1136/bjophthalmol-2020-317164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。